癌症中的费罗普托特疗法:益处,副作用和风险
Jiandong Diao1, Yuanyuan Jia1, Enyong Dai1
12nd Inpatient Area of Oncology and Hematology Department, China-Japan Union Hospital of Jilin University, Changchun, Jilin, 130031, China.
Molecular cancer
|May 3, 2024
概括
作为一种细胞死亡方法的铁灭,在癌症治疗中表现有前途,但会引起副作用. 本综述涵盖了铁亡的益处,器官损伤等风险以及缓解策略.
科学领域:
- 生物医学科学 生物医学科学
- 在瘤学瘤学.
- 细胞死亡研究 细胞死亡研究
背景情况:
- 铁亡是一种受调节的细胞死亡,涉及铁和脂质过氧化.
- 它最初是针对RAS突变癌症进行研究的,但具有更广泛的治疗潜力.
- 铁化可以补充现有的癌症治疗方法,如化疗和免疫疗法.
研究的目的:
- 在癌症治疗中审查ferroptosis诱导的优势.
- 为了提供与铁灭症相关的副作用的概述.
- 探索铁灭的副作用的机制和缓解策略.
主要方法:
- 关于铁灭症研究的文献综述.
- 对已记录的临床和临床前发现进行分析.
- 检查基础上的分子机制ferroptosis及其副作用.
主要成果:
- 铁灭诱导在各种癌症类型中提供治疗益处.
- 显著的副作用包括免疫细胞死亡,器官损伤和缓冲症.
- 二次瘤发生的可能性也令人担忧.
结论:
- 铁亡是一种有前途的癌症治疗方法,但需要仔细管理副作用.
- 了解这些机制是制定减轻毒性策略的关键.
- 需要进一步的研究来优化基于铁亡的治疗方法,并尽量减少不良事件.
更多相关视频
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


